Zobrazeno 1 - 10
of 81
pro vyhledávání: '"Anca D Askanase"'
Autor:
Munther Khamashta, Richard A Furie, Ian N Bruce, Ronald van Vollenhoven, Murray B Urowitz, Andreas Schwarting, Ming-hui Zhao, Anca D Askanase, Mark Daniels, Andrew S Bomback, Angela Carroll, Bernie Rubin, Roger Abramino Levy
Publikováno v:
Lupus Science and Medicine, Vol 11, Iss 1 (2024)
Our 2022 published working definition of disease modification in systemic lupus erythematosus (SLE) was ‘minimising disease activity with the fewest treatment-associated toxicities and slowing or preventing organ damage progression’. The objectiv
Externí odkaz:
https://doaj.org/article/3978731451ab4b52af1def567e5d6564
Autor:
Joan T Merrill, Kenneth Kalunian, Sandra Garces, Anca D Askanase, Elaine Karis, May Mo, Cassandra E Milmont
Publikováno v:
Lupus Science and Medicine, Vol 10, Iss 2 (2023)
SLE is a complex autoimmune disease with considerable unmet need. Numerous clinical trials designed to investigate novel therapies are actively enrolling patients straining limited resources and creating inefficiencies that increase enrolment challen
Externí odkaz:
https://doaj.org/article/2fa9074c62ef463690b0a0c71f60cdae
Autor:
Cynthia Aranow, Maria Dall'Era, Meggan Mackay, Diane L Kamen, Wei Tang, Mimi Y Kim, Cristina Arriens, Anca D Askanase, Leila Khalili, Julia Barasch
Publikováno v:
Lupus Science and Medicine, Vol 10, Iss 2 (2023)
Objective There is a lack of data on the use of telemedicine (TM) in SLE. SLE outcome measures remain complex, and clinicians and clinical trialists have raised concerns about the accuracy of virtual disease activity measures. This study evaluates th
Externí odkaz:
https://doaj.org/article/c2f0777d2f184261811fc1b174d00200
Autor:
Victoria P Werth, Ronald F van Vollenhoven, Kenneth Kalunian, Karen Costenbader, Eric F Morand, Peter Lipsky, Christopher Reed, Laura Eve Schanberg, Zahi Touma, Anca D Askanase, Lauren Bloch, Timothy Franson, L Inês, Joy Buie, MaryBeth Son
Publikováno v:
Lupus Science and Medicine, Vol 10, Iss 1 (2023)
Drug development in lupus has improved over the past 10 years but still lags behind that of other rheumatic disease areas. Assessment of prospective lupus therapies in clinical trials has proved challenging for reasons that are multifactorial includi
Externí odkaz:
https://doaj.org/article/7f388926b5e646f787d5f1417c696325
Publikováno v:
Lupus Science and Medicine, Vol 10, Iss 1 (2023)
Objective The Lupus Foundation of America Rapid Evaluation of Activity in Lupus (LFA-REAL) system is a novel and simple SLE disease activity instrument, consisting of a tandem clinician-reported (ClinRO) and patient-reported (PRO) outcome measure. Th
Externí odkaz:
https://doaj.org/article/6c0f13f95f8c4b9690773c19bca2378c
Autor:
Cynthia Aranow, Maria Dall’Era, Mimi Kim, Meggan Mackay, Wei Tang, Cristina Arriens, Anca D Askanase, Leila Khalili, Diane Kamen, Julia Barasch
Publikováno v:
Lupus Science and Medicine, Vol 9, Iss Suppl 3 (2022)
Externí odkaz:
https://doaj.org/article/e3ec327a40b042878b0d4724fbe2177f
Autor:
Joan T Merrill, Munther Khamashta, Daniel J Wallace, Kenneth Kalunian, Susan Manzi, Cynthia Aranow, Michelle A Petri, Rosalind Ramsey-Goldman, Ian N Bruce, Guillermo Ruiz-Irastorza, Ronald van Vollenhoven, Ellen M Ginzler, Graciela S Alarcón, John G Hanly, Ann Elaine Clarke, Juanita Romero-Diaz, Caroline Gordon, Sang-Cheol Bae, Anisur Rahman, Paul R Fortin, Dafna D Gladman, Kristján Steinsson, Ola Nived, Andreas Jönsen, Manuel Ramos-Casals, Murat Inanc, Diane L Kamen, Søren Jacobsen, Jorge Sanchez-Guerrero, Murray Urowitz, David Isenberg, Sasha Bernatsky, Luck Lukusa, S Sam Lim, Anca D Askanase, A Zoma, Mary-Anne Dooley, Christine Peschken, Celline C Almeida-Brasil
Publikováno v:
Lupus Science and Medicine, Vol 9, Iss 1 (2022)
Objective To evaluate hydroxychloroquine (HCQ)-related retinal toxicity in the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort.Methods Data were collected at annual study visits between 1999 and 2019. We followed patients
Externí odkaz:
https://doaj.org/article/7fb8a7eb741647faa783eeb570e82d53
Autor:
Richard Furie, Ian N Bruce, Ronald van Vollenhoven, Maria Dall'Era, Andreas Schwarting, Ming-hui Zhao, Anca D Askanase, Roger A Levy, Mark Daniels, Andrew S Bomback, Angela Carroll, Holly A Quasny
Publikováno v:
Lupus Science and Medicine, Vol 9, Iss 1 (2022)
Disease modification has become a well-established concept in several therapeutic areas; however, no widely accepted definition of disease modification exists for SLE.We reviewed established definitions of disease modification in other conditions and
Externí odkaz:
https://doaj.org/article/677b9fbf4bef480ea911147614263bae
Autor:
Wei Tang, Yevgeniya Gartshteyn, George Danias, Anca D Askanase, Leila Khalili, Cathy Guo, Youngwan Kim, Alessandro Marone, Tommy Chen, Andreas Hielscher
Publikováno v:
Lupus Science and Medicine, Vol 8, Iss 1 (2021)
Externí odkaz:
https://doaj.org/article/6c56753967a845f8ad7ee1e5eb28ab89
Autor:
Victoria P Werth, Ronald F van Vollenhoven, Laurent Arnaud, Ricard Cervera, Andrea Doria, Angela Tincani, Matthias Schneider, Marta Mosca, Nathalie Costedoat-Chalumeau, Cynthia Aranow, Michelle A Petri, Ian N Bruce, Dimitrios T Boumpas, Michael M Ward, Manuel Francisco Ugarte-Gil, Bernardo A Pons-Estel, Ann Elaine Clarke, Juanita Romero-Diaz, Caroline Gordon, Sang-Cheol Bae, Anisur Rahman, Murat Inanc, Søren Jacobsen, George Bertsias, Xavier Mariette, Thomas Dörner, Hendrika Bootsma, Josef Smolen, Mandana Nikpour, David Jayne, Martin Aringer, David Isenberg, László Czirják, Annegret Kuhn, Y K Onno Teng, Frédéric A Houssiau, Hermine Brunner, Eric Morand, Carlos Vasconcelos, Guillermo Pons-Estel, Graciela Alarcon, Eloisa Bonfa, Alexandre Voskuyl, Raquel Faria, Anne Voss, Maarten Limper, Anca D Askanase, Sandra Navarra, Cindy Coney, Ruth Fritsch-Stork, Bernadette van Leeuw, Michel Tsang-a-Sjoe, Rebecca Fischer, Marzena Helena Olesinska, Blanca Rubio, Yehuda Schoenfeld, Elena Zakharhova
Publikováno v:
Lupus Science and Medicine, Vol 8, Iss 1 (2021)
Externí odkaz:
https://doaj.org/article/c4212b93061f4683be271e1376e1a0b4